A Screened GPR1 Peptide Exerts Antitumor Effects on Triple-Negative Breast Cancer

A Screened GPR1 Peptide Exerts Antitumor Effects on Triple-Negative Breast Cancer

The adipokine chemerin has been considered an important regulator of tumor immune surveillance. Chemerin recruits leukocytes through the receptor CMKLR1 to improve clinical outcomes of tumors and overall patient survival, but the role of GPR1 in tumors has not been widely investigated. Here, we foun...

Full description

Bibliographic Details
Main Authors:	Chen Huang, Xiao-Yong Dai, Jia-Xuan Cai, Jie Chen, Bao Bei Wang, Wen Zhu, Esther Wang, Wei Wei, Jian V. Zhang
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	Molecular Therapy: Oncolytics
Online Access:	http://www.sciencedirect.com/science/article/pii/S2372770520301303

Similar Items

Dezocine, An Opioid Analgesic, Exerts Antitumor Effects in Triple-Negative Breast Cancer by Targeting Nicotinamide Phosphoribosyltransferase
by: Chenyang Xue, et al.
Published: (2021-04-01)

Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer.
by: Mahavir B Chougule, et al.
Published: (2011-03-01)

Yiqi Formula Enhances the Antitumor Effects of Erlotinib for Treatment of Triple-Negative Breast Cancer Xenografts
by: Ming-juan Liao, et al.
Published: (2014-01-01)

Fenofibrate Exerts Antitumor Effects in Colon Cancer via Regulation of DNMT1 and CDKN2A
by: Rui Kong, et al.
Published: (2021-01-01)

Hydrogen sulfide and its donors: Novel antitumor and antimetastatic therapies for triple-negative breast cancer
by: Haonan Li, et al.
Published: (2020-07-01)

Peptide density targets and impedes triple negative breast cancer metastasis
by: Daxing Liu, et al.
Published: (2018-07-01)

Juglone exerts antitumor effect in ovarian cancer cells
by: Fang Fang, et al.
Published: (2015-06-01)

Antitumor Actions of Intratumoral Delivery of Membrane-Fused Mitochondria in a Mouse Model of Triple-Negative Breast Cancers
by: Chang JC, et al.
Published: (2020-06-01)

Classification of triple-negative breast cancers based on Immunogenomic profiling
by: Yin He, et al.
Published: (2018-12-01)

The Heparan Sulfate Binding Peptide in Tumor Progression of Triple-Negative Breast Cancer
by: Carina Mucciolo Melo, et al.
Published: (2021-08-01)

Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines
by: Paola Maria Bonaccorsi, et al.
Published: (2019-10-01)

Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells.
by: Lei Hou, et al.
Published: (2013-01-01)

Systems Medicine Design for Triple-Negative Breast Cancer and Non-Triple-Negative Breast Cancer Based on Systems Identification and Carcinogenic Mechanisms
by: Shan-Ju Yeh, et al.
Published: (2021-03-01)

Essential oil of Cyphostemma juttae (Vitaceae): Chemical composition and antitumor mechanism in triple negative breast cancer cells.
by: Pietro Zito, et al.
Published: (2019-01-01)

IDO Inhibition Facilitates Antitumor Immunity of Vγ9Vδ2 T Cells in Triple-Negative Breast Cancer
by: Peng Li, et al.
Published: (2021-07-01)

The GPR171 pathway suppresses T cell activation and limits antitumor immunity
by: Yuki Fujiwara, et al.
Published: (2021-10-01)

Aloperine Exerts Antitumor Effects on Bladder Cancer in vitro
by: Zhang L, et al.
Published: (2020-10-01)

Inhibition of lipid metabolism exerts antitumor effects on rhabdomyosarcoma
by: Satoshi Miyagaki, et al.
Published: (2021-09-01)

ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control
by: Xiaofeng Dai, et al.
Published: (2019-10-01)

miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer
by: Silvia Martini, et al.
Published: (2021-05-01)

The Prolactin Inducible Protein Modulates Antitumor Immune Responses and Metastasis in a Mouse Model of Triple Negative Breast Cancer
by: Chidalu A. Edechi, et al.
Published: (2021-03-01)

Plasmodium infection inhibits triple negative 4T1 breast cancer potentially through induction of CD8+ T cell-mediated antitumor responses in mice
by: Jianhua Pan, et al.
Published: (2021-06-01)

GPR 30 - Zielgerichtete Therapie triple-negativer Mammakarzinome durch Bindung des östrogensensitiven Rezeptors GPR 30
by: vom Orde, Sandra
Published: (2017)

Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer
by: Shanshan Wang, et al.
Published: (2021-01-01)

Triple-Negative Breast Cancer
by: Quyen D. Chu, et al.
Published: (2012-01-01)

Metabolic reprogramming in triple-negative breast cancer
by: Zhanyu Wang, et al.
Published: (2020-02-01)

The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice
by: Christophe Mallet, et al.
Published: (2021-03-01)

Huangqi Fuzheng decoction exerts antitumor activity by inhibiting cell growth and inducing cell death in osteosarcoma
by: Jinghao Qin, et al.
Published: (2019-06-01)

Coix Seed Oil Exerts an Anti–Triple-Negative Breast Cancer Effect by Disrupting miR-205/S1PR1 Axis
by: Ting Fang, et al.
Published: (2020-09-01)

Bisdemethoxycurcumin (BDMC) inhibits cell proliferation and metastasis through the suppression of GPR161/mTOR signaling pathway in triple negative breast cancer cells
by: Meng-Tien Lu, et al.
Published: (2018)

Targeting the EGFR/PCNA signaling suppresses tumor growth of triple-negative breast cancer cells with cell-penetrating PCNA peptides.
by: Yung-Luen Yu, et al.
Published: (2013-01-01)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
by: Chen B, et al.
Published: (2018-12-01)

The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects
by: Magdalena Kotańska, et al.
Published: (2021-08-01)

Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells
by: Yanling Liu, et al.
Published: (2020-01-01)

Metabolic Reprogramming in Triple-Negative Breast Cancer
by: Xiangyu Sun, et al.
Published: (2020-03-01)

Antitumor Activity of Pulvomycin via Targeting Activated-STAT3 Signaling in Docetaxel-Resistant Triple-Negative Breast Cancer Cells
by: Woong Sub Byun, et al.
Published: (2021-04-01)

To characterize the expression profile and screen for the ligand of GPR114
by: Ying Wen Chen, et al.
Published: (2019)

Immunotherapeutic interventions of Triple Negative Breast Cancer
by: Zehuan Li, et al.
Published: (2018-05-01)

Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics
by: Nan Wang, et al.
Published: (2021-08-01)

Pan-Cancer Analysis and Drug Formulation for GPR139 and GPR142
by: Aman Chandra Kaushik, et al.
Published: (2021-02-01)